While IFN-γ appears to be a possible marker of treatment response and IFN-λ3 selectively identifies severe disease stages, soluble HVEM and bacterial translocation would thus appear to be features of all stages of PBC. The gene discussed is IFNL3; the disease is primary biliary cholangitis.